Pseudomonas aeruginosa cytotoxin ExoU is injected into phagocytic cells during acute pneumonia.

Infection and Immunity
Maureen H Diaz, Alan R Hauser

Abstract

ExoU, a cytotoxin translocated into host cells via the type III secretion system of Pseudomonas aeruginosa, is associated with increased mortality and disease severity. We previously showed that impairment of recruited phagocytic cells allowed survival of ExoU-secreting P. aeruginosa in the lung. Here we analyzed types of cells injected with ExoU in vivo using translational fusions of ExoU with a beta-lactamase reporter (ExoU-Bla). Cells injected with ExoU-Bla were detectable in vitro but not in vivo, presumably due to the rapid cytotoxicity induced by the toxin. Therefore, we used a noncytotoxic ExoU variant, designated ExoU(S142A)-Bla, to analyze injection in vivo. We determined that phagocytic cells in the lung were frequently injected with ExoU(S142A). Early during infection, resident macrophages constituted the majority of cells into which ExoU was injected, but neutrophils and monocytes became the predominant types of cells into which ExoU was injected upon recruitment into the lung. We observed a modest preference for injection into neutrophils over injection into other cell types, but in general the repertoire of injected immune cells reflected the relative abundance of these cells in the lung. Our results indicate that...Continue Reading

References

Jul 1, 1997·The American Journal of Physiology·T TamakiT Shiraishi
Jul 1, 1997·The American Journal of Physiology·K M RidgeJ L Sznajder
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·T L YahrD W Frank
Sep 24, 1999·The Journal of Clinical Investigation·K KurahashiJ P Wiener-Kronish
May 24, 2001·The Journal of Infectious Diseases·A Roy-BurmanJ P Wiener-Kronish
Jun 22, 2001·Journal of Bacteriology·V Finck-Barbançon, D W Frank
Apr 5, 2002·Clinical Microbiology Reviews·Jeffrey B LyczakGerald B Pier
Apr 6, 2002·American Journal of Respiratory and Critical Care Medicine·Jean Chastre, Jean-Yves Fagon
Jun 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Matthew C WolfgangStephen Lory
Sep 18, 2004·Reviews of Physiology, Biochemistry and Pharmacology·J T Barbieri, J Sun
Sep 25, 2004·Molecular Microbiology·Hiromi Sato, Dara W Frank
Nov 24, 2004·Infection and Immunity·Ciara M Shaver, Alan R Hauser
Dec 25, 2004·Infection and Immunity·Shira D P Rabin, Alan R Hauser
Apr 2, 2005·Clinics in Chest Medicine·Jordi RelloAlejandro Rodríguez
Jul 30, 2005·Science·Melanie M MarketonOlaf Schneewind
Dec 3, 2005·Nature Reviews. Immunology·Siamon Gordon, Philip R Taylor
Dec 28, 2007·PLoS Pathogens·Kaoru GeddesFred Heffron
Jul 30, 2008·Infection and Immunity·Maureen H DiazAlan R Hauser

❮ Previous
Next ❯

Citations

Jan 11, 2012·Proceedings of the National Academy of Sciences of the United States of America·Vanderlene L KungAlan R Hauser
Aug 1, 2012·PloS One·Carolina Diettrich Mallet de LimaAlessandra Mattos Saliba
Oct 8, 2013·PLoS Pathogens·Roger D PechousWilliam E Goldman
Jan 15, 2014·Respiratory Physiology & Neurobiology·Qin WangYuanlin Song
Feb 13, 2015·Critical Care : the Official Journal of the Critical Care Forum·Teiji SawaJeanine P Wiener-Kronish
Aug 16, 2011·Microbes and Infection·Elise G LavoieBarbara I Kazmierczak
Mar 13, 2014·Cellular Microbiology·Carolina Diettrich Mallet de LimaAlessandra Mattos Saliba
Apr 24, 2015·Medical Microbiology and Immunology·Luiz Gonzaga da CunhaAlessandra Mattos Saliba
Jul 8, 2015·Chemistry and Physics of Lipids·Tatiana KondakovaCécile Duclairoir Poc
Aug 15, 2013·Gut·Chih-Hsien ChuangCheng-Hsun Chiu
Jun 20, 2015·PLoS Pathogens·Stephanie M RangelAlan R Hauser
Aug 8, 2015·PLoS Pathogens·Roger D Pechous, William E Goldman
Mar 21, 2015·Organic & Biomolecular Chemistry·Gaganpreet KaurNarinder Singh
Mar 19, 2015·MBio·David BursteinEhud Banin
Jun 17, 2016·Microbiology and Molecular Biology Reviews : MMBR·Marietta Flores-DíazAntje Flieger
Aug 5, 2017·PLoS Pathogens·Michael A PazosBryan P Hurley
Mar 30, 2017·Frontiers in Cellular and Infection Microbiology·Xiaolei PanWeihui Wu
Jan 18, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yan SunEric Pearlman
Apr 8, 2020·Toxins·Rudolf LucasJürg Hamacher
Aug 12, 2020·Cellular Microbiology·Stéphanie BouillotPhilippe Huber
Sep 8, 2019·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·João BotelhoLuísa Peixe
May 12, 2021·Antimicrobial Agents and Chemotherapy·Nhu T Q NguyenBinh An Diep
Jun 3, 2021·Proceedings of the National Academy of Sciences of the United States of America·Maurice DiwoAntje Flieger
Jun 29, 2021·Virulence·Charles D MorinGee W Lau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.